Publications by authors named "Gordon G Wang"

Carcinoid tumors and pancreatic endocrine tumors are uncommon neuroendocrine neoplasms, and their genetic alterations are not well characterized. These tumors have site-specific differences in neuroendocrine characteristics, clinical course and genetic alterations. We compared clinicopathological features and loss of heterozygosity of chromosomes 11q, 16q and 18, and BRAF gene mutations in 47 patients with neuroendocrine tumors including 16 with pancreatic endocrine tumors, 15 with nonileal carcinoid tumors and 16 with ileal carcinoid tumors.

View Article and Find Full Text PDF

Background: We and others have shown that mixed allogeneic chimerism induces donor-specific tolerance to composite tissue allografts across major histocompatibility complex barriers without the need for immunosuppression. However, a delay period between bone marrow transplantation and limb allotransplantation is required, making such protocols impractical for clinical application. This study eliminates this delay period in a rat hind limb allotransplantation model by performing mixed allogeneic chimerism induction and transplantation "simultaneously.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Gordon G Wang"

  • - Gordon G Wang's research primarily focuses on the genetic alterations in neuroendocrine tumors, with a particular emphasis on the frequent loss of chromosome 18 observed in ileal carcinoid tumors, highlighting the site-specific differences in tumor characteristics and genetic profiles.
  • - His work also includes investigating tolerance induction protocols for composite tissue allotransplantation, exploring the feasibility of simultaneous mixed allogeneic chimerism induction and limb transplantation in a rat model, which could have significant clinical implications for organ transplantation.
  • - The findings from his studies contribute valuable insights into the clinicopathological features of different neuroendocrine tumors and offer innovative approaches to enhance tolerance in transplantation, potentially reducing the need for immunosuppression in clinical settings.